Health Dictionary Find a Doctor

Hepatic encephalopathy classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]

Overview

Hepatic encephalopathy may be classified based on underlying liver disease into three types type A (acute), Type B (bypass) and type C (cirrhosis). The evaluation of severity of persistent hepatic encephalopathy is based on the West Haven Criteria. It includes mental status, level of impairment of autonomy, changes in consciousness, intellectual function, behavior, and the dependence on therapeutic factors into grading.

Classification

Based on underlying liver disease

According to world congress of gastroenterology, hepatic encephalopathy can be subdivided based on underlying liver disease association into type A, B, and C[1][2][3]

Based on duration and characteristics of hepatic encephalopathy

Based on the duration and characteristics of hepatic encephalopathy, it can be classified into episodic, persistent, and minimal[4]

Based on severity of the disease

The evaluation of severity of persistent hepatic encephalopathy is based on the West Haven Criteria.[2][1]

West Haven Criteria

References

  1. 1.0 1.1 Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seeff L, Levy LL. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology 1977; 72: 573-83.
  2. 2.0 2.1 Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT (2002). “Hepatic encephalopathy–definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998”. Hepatology. 35 (3): 716–21. doi:10.1053/jhep.2002.31250. PMID 11870389.
  3. Leise MD, Poterucha JJ, Kamath PS, Kim WR (2014). “Management of hepatic encephalopathy in the hospital”. Mayo Clin Proc. 89 (2): 241–53. doi:10.1016/j.mayocp.2013.11.009. PMC 4128786. PMID 24411831.
  4. Al Sibae MR, McGuire BM (2009). “Current trends in the treatment of hepatic encephalopathy”. Ther Clin Risk Manag. 5 (3): 617–26. PMC 2724191. PMID 19707277.
  5. Bajaj JS, Hafeezullah M, Hoffmann RG, Saeian K (2007). “Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations”. Am J Gastroenterol. 102 (9): 1903–09. doi:10.1111/j.1572-0241.2007.01424.x. PMID 17640323.
  6. Bleibel W, Al-Osaimi AM (2012). “Hepatic encephalopathy”. Saudi J Gastroenterol. 18 (5): 301–9. doi:10.4103/1319-3767.101123. PMC 3500018. PMID 23006457.
  7. Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R (2007). “Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy”. Hepatology. 45 (3): 549–59. doi:10.1002/hep.21533. PMID 17326150.

Template:WH Template:WS

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH